Clinical Trial Update: Intra-tracheal Instillation of Budesonide to Prevent Chronic Lung Disease [Phase 4]

View source ↗

Summary

Phase 4 trial update on intra-tracheal budesonide to prevent chronic lung disease in extremely premature infants with acute lung injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infant Extremely Premature
• Lung Disease of Prematurity
• Lung Injury

Drugs mentioned

• Budesonide (BUDESONIDE)

Snippet

Sponsor: University of Arizona | Conditions: Infant, Extremely Premature, Acute Lung Injury | Phase 4 | Status: UNKNOWN